Abbott makes medical devices like glucose monitors (FreeStyle Libre), diagnostic tests, and nutrition brands like Ensure.
Abbott Laboratories (ABT) is expected to report earnings on Wednesday, October 21, 2026, before the open. Estimated release time 07:35 ET. Consensus EPS estimate is $1.42.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-16 | Jun 2026 qtr | $1.28 | $1.31 | +2.3% | $12.59B |
| 2026-04-16 | Mar 2026 qtr | $1.14 | $1.15 | +0.9% | $11.16B |
| 2026-01-22 | Dec 2025 qtr | $1.50 | $1.50 | +0.0% | $11.46B |
| 2025-10-15 | Sep 2025 qtr | $1.30 | $1.30 | +0.0% | $11.37B |
| 2025-07-17 | Jun 2025 qtr | $1.26 | $1.26 | +0.0% | $11.14B |
| 2025-04-16 | Mar 2025 qtr | $1.07 | $1.09 | +1.9% | $10.36B |
| 2025-01-22 | Dec 2024 qtr | $1.34 | $1.34 | +0.0% | $10.97B |
| 2024-10-16 | Sep 2024 qtr | $1.20 | $1.21 | +0.8% | $10.63B |
ABT has beaten consensus EPS in 8 of its last 8 scored quarters.
ABT pays a quarterly dividend, currently yielding 2.46%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-10-15 | $0.63 | 2026-11-16 |
| 2026-07-15 | $0.63 | 2026-08-17 |
| 2026-04-15 | $0.63 | 2026-05-15 |
| 2026-01-15 | $0.63 | 2026-02-13 |
| 2025-10-15 | $0.59 | 2025-11-17 |
| 2025-07-15 | $0.59 | 2025-08-15 |